A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : LABC

Search Conditions:
Search Keyword : LABC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: LABC
Appearance Frequency: 496 time(s)
Long forms: 18

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
locally advanced breast cancer
(430 times)
Neoplasms
(276 times)
pCR (70 times)
OS (68 times)
DFS (49 times)
1988 Patient compliance with aggressive multimodal therapy in locally advanced breast cancer.
levator ani/bulbocavernosus
(25 times)
Toxicology
(12 times)
DBP (4 times)
s.c (4 times)
TE (4 times)
2001 Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues.
lymphadenosis benigna cutis
(10 times)
Dermatology
(8 times)
ACA (3 times)
ECM (3 times)
ALA (1 time)
1960 Lymphadenosis benigna cutis (LABC), its nature, course and prognosis.
locally advanced noninflammatory breast cancer
(8 times)
Neoplasms
(8 times)
CT (3 times)
pCR (3 times)
HR (2 times)
1997 Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer.
lateral antebrachial cutaneous nerve
(6 times)
General Surgery
(4 times)
MABC (2 times)
PCMN (1 time)
RASP (1 time)
1985 The overlap pattern of the lateral antebrachial cutaneous nerve and the superficial branch of the radial nerve.
locally advanced BC
(3 times)
Neoplasms
(3 times)
BC (3 times)
AUC (1 time)
BD (1 time)
2014 Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.
lower airway bacterial colonization
(2 times)
Pulmonary Medicine
(1 time)
CB (1 time)
CFU (1 time)
CI (1 time)
1999 Risk factors for lower airway bacterial colonization in chronic bronchitis.
luminal A breast cancer
(2 times)
Oncogenes
(1 time)
TNBC (2 times)
HR-MAS (1 time)
NMR (1 time)
2013 Triple negative breast cancers have a reduced expression of DNA repair genes.
lactic acid bacteria count
(1 time)
Microbiology
(1 time)
ASFBC (1 time)
PBC (1 time)
SCC (1 time)
2010 Microbiological quality of raw milk produced in Estonia.
10  local-regionally advanced breast cancer
(1 time)
Neoplasms
(1 time)
DSS (1 time)
OS (1 time)
PMRT (1 time)
2012 Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.
11  locally advanced breast cancer patients
(1 time)
Neoplasms
(1 time)
--- 2015 Diagnostic significance of alternative splice variants of REST and DOPEY1 in the peripheral blood of patients with breast cancer.
12  locally advanced non-IBC
(1 time)
Biochemistry
(1 time)
CI (1 time)
IBC (1 time)
OR (1 time)
2017 Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer.
13  locally advanced noninflammatory or inflammatory breast carcinoma
(1 time)
Neoplasms
(1 time)
CR (1 time)
DFS (1 time)
FEC (1 time)
1998 Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
14  locally advanced nonoperable breast cancer
(1 time)
Neoplasms
(1 time)
LVEF (1 time)
MBC (1 time)
2009 Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
15  locally advanced, invasive breast cancers with chest wall/breast skin involvement
(1 time)
Neoplasms
(1 time)
BMI (1 time)
CI (1 time)
ER (1 time)
2013 Risk factors for inflammatory breast cancer and other invasive breast cancers.
16  locoregionally metastatic breast cancer
(1 time)
General Surgery
(1 time)
HA-cisplatin (1 time)
2009 A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo.
17  lowest acceptable value of bladder capacity
(1 time)
Urologic Diseases
(1 time)
OBC (1 time)
PVR (1 time)
2017 Lowest Acceptable Bladder Capacity for Interpretation of Uroflowmetry Tests in Children.
18  lymphadenosis cutis benigna
(1 time)
Dermatology
(1 time)
ECM (1 time)
1990 [Anti-Borrelia burgdorferi antibodies in chronic erythema migrans, benign lymphadenosis cutis, scleroderma and scleroatrophic lichen].